Quick answer: Oxidative stress is a biological imbalance in which reactive molecules exceed the body’s ability to regulate them. It may contribute to endothelial dysfunction, inflammation, LDL oxidation, and atherosclerosis, but it is not a stand-alone diagnosis. Glutathione supports cellular antioxidant defense. Tests for total glutathione, F2-isoprostanes, oxidized LDL, and cardiovascular myeloperoxidase (MPO) measure selected parts of this biology; they do not replace blood pressure, standard lipids, glucose assessment, kidney evaluation, clinical risk calculation, or cardiovascular imaging.
Article history: Originally published July 10, 2026. Updated August 28, 2026.
Commercial disclosure: Ulta Lab Tests offers laboratory-testing services and may link to tests or panels discussed on this page. This content is educational and does not provide individual diagnosis or treatment.

This is a specialist supporting guide about glutathione, redox balance, lipid peroxidation, and selected oxidative-stress biomarkers. For the broader evidence-based testing pathway, start with Heart Health Blood Tests: Cholesterol, ApoB, Lp(a), hs-CRP, and Cardiac Risk. That parent guide owns the larger questions of cardiovascular screening, risk assessment, treatment monitoring, cardiac injury, and heart-failure biomarkers.
For deeper explanations of conventional lipids and inflammation, use the guides to cholesterol blood tests, including LDL-C, non-HDL-C, triglycerides, and ApoB and CRP versus hs-CRP. This page focuses on the narrower question of what oxidative-stress testing may add after established cardiovascular risk factors have been addressed.
If you are new to laboratory testing, review The Complete Guide to Lab Tests and Blood Work. Use How to Read and Understand Your Lab Results for reference intervals, units, flags, and trends, and see Direct-Access Lab Testing: How It Works and What to Expect before selecting, preparing for, and following up on a self-ordered test.
Oxidative stress describes an imbalance between oxidants and the systems that regulate or neutralize them. Reactive oxygen species include free radicals and other oxygen-containing molecules produced during normal energy metabolism, immune activity, exercise, and cell signaling. At controlled levels, ROS are necessary. When their production is sustained or antioxidant defenses are impaired, they may alter lipids, proteins, DNA, mitochondria, and blood-vessel tissue.[2]
Oxidative stress is not a disease, a symptom pattern, or one body-wide value. It is a biological process. Different tests measure different downstream products or components of antioxidant defense, and a result from blood or urine may not represent what is happening in a particular tissue.
Oxidative activity may increase with cigarette smoke, air pollution, poorly controlled blood sugar, obesity and insulin resistance, chronic inflammation, certain infections, kidney or liver dysfunction, and some occupational or environmental exposures. Acute illness and strenuous or unaccustomed exercise can also change selected markers. Many of these factors overlap with established cardiovascular risks, but measuring an oxidative-stress biomarker does not determine which factor caused the result.
High blood pressure, unhealthy cholesterol levels, smoking, diabetes, obesity, physical inactivity, and family history remain central to cardiovascular-risk assessment.[3] Specialty oxidative-stress testing should not distract from identifying and managing those established risks.
Glutathione is a small molecule made from glutamate, cysteine, and glycine. It is present in most cells and participates in antioxidant defense, detoxification reactions, protein regulation, and maintenance of cellular redox balance.
Glutathione also works with glutathione peroxidase, an enzyme that helps convert hydrogen peroxide and lipid peroxides into less-reactive products. Research links altered glutathione biology with several cardiovascular mechanisms, but that does not make glutathione a routine heart-disease screening marker.[4]
A Total Glutathione Test measures total glutathione in whole blood. It provides information about one component of antioxidant defense. It does not measure glutathione in the heart or artery wall, establish why a value is high or low, diagnose cardiovascular disease, or determine a supplement dose.
The endothelium is the thin cellular lining inside blood vessels. It helps regulate vascular tone, inflammation, clotting, and movement of substances into the artery wall. Excess oxidative activity can reduce nitric oxide availability and interfere with normal vessel relaxation. This may contribute to endothelial dysfunction and a vascular environment that favors inflammation.[2]
LDL particles can enter the artery wall and undergo chemical changes, including oxidation. Modified LDL may stimulate inflammatory signaling and be taken up by macrophages. These immune cells can become cholesterol-filled foam cells, an important feature of developing atherosclerotic plaque.
An oxidized LDL result answers a different question from LDL cholesterol or ApoB. LDL-C estimates cholesterol carried within LDL particles, while ApoB estimates the number of atherogenic particles. Oxidized LDL measures one form of particle modification. The clinical roles and limitations of LDL-C and ApoB belong to conventional cholesterol risk assessment.
Oxidative stress and inflammation can reinforce one another. Activated immune cells may generate oxidants, while oxidative products can activate inflammatory pathways. Myeloperoxidase is an enzyme released mainly by certain white blood cells and participates in antimicrobial, inflammatory, and oxidative reactions. Cardiovascular MPO has been studied as a vascular-risk biomarker, but assay and sampling standardization and its role in routine practice remain limitations.[6]
High-sensitivity C-reactive protein measures low concentrations of a systemic inflammation marker; it does not directly measure oxidative stress or identify inflammation in the artery wall. Standard CRP and hs-CRP answer related but different inflammation questions.
Oxidative and inflammatory pathways may influence plaque formation, cellular injury, and plaque composition. Mitochondria also produce ROS during normal metabolism, and disturbed mitochondrial function can increase oxidative activity while reducing efficient energy production. These mechanisms are biologically important, but a blood or urine biomarker cannot determine whether a specific plaque is present, growing, stable, or vulnerable.
The most useful testing strategy is question-first. Established measures generally come before specialist-directed oxidative-stress biomarkers. “Specialty” does not mean “better”; it means the test answers a narrower question and often has less-standardized interpretation.

| Testing tier | Examples | Appropriate role |
|---|---|---|
| Common cardiovascular-risk assessment | Blood pressure, lipid panel, glucose or Hemoglobin A1c, kidney evaluation when appropriate | Establishes common, clinically actionable cardiovascular and cardiometabolic context |
| Risk-based cardiovascular testing | ApoB, lipoprotein(a), hs-CRP | Refines a defined particle-burden, inherited-risk, or inflammation question |
| Specialist-directed oxidative-stress testing | Total glutathione, F2-isoprostanes, oxidized LDL, cardiovascular MPO | Measures selected antioxidant, lipid-peroxidation, LDL-modification, or enzyme-related markers as adjuncts |
| Monitoring | Repeat an established or specialty marker only when the trend will answer a follow-up question | No universal oxidative-stress retesting schedule; comparable methods and conditions matter |
Blood pressure, tobacco exposure, family history, age, medications, body composition, physical activity, and a validated risk estimate are also important, even though they are not laboratory tests.
| Test | What it measures | What it may add | Important limitation |
|---|---|---|---|
| Total Glutathione Test | Total glutathione in whole blood | Information about one component of antioxidant defense | Does not measure tissue-specific glutathione, diagnose heart disease, identify a cause, or prescribe supplementation |
| F2-Isoprostane Creatinine Ratio Test | Urinary F2-isoprostanes normalized to urine creatinine | A marker of lipid peroxidation; mass-spectrometry-based F2-isoprostane measurement is widely used in oxidative-stress research[5] | Does not localize oxidation or identify its cause; a higher result is not specific to cardiovascular disease |
| Oxidized LDL Test | LDL particles or epitopes that have undergone oxidative modification, according to the assay | Selected context about LDL oxidation and related vascular biology | Does not replace LDL-C, non-HDL-C, ApoB, Lp(a), overall risk assessment, or imaging |
| Cardio IQ™ Myeloperoxidase Test | Circulating cardiovascular myeloperoxidase enzyme | Selected information about an enzyme involved in inflammatory and oxidative reactions | Not a routine stand-alone screen and must not be confused with an MPO antibody test used in autoimmune-vasculitis evaluation |
Important MPO distinction: The cardiovascular MPO enzyme test and an MPO antibody test are different tests used for different clinical questions. Do not substitute one for the other based on the shared abbreviation.
Laboratory tests measure circulating or urinary markers; imaging evaluates anatomy and plaque. If the clinical question is whether plaque is present or how it is changing, review what labs can and cannot tell you about arterial plaque and discuss whether imaging or another cardiovascular evaluation is appropriate.

There is no recommendation that every adult receive an oxidative-stress panel. A specialty test may be reasonable to discuss when all of the following are true:
Broad oxidative-stress or antioxidant panels are generally less useful when they are ordered without a defined question. More biomarkers can create more incidental abnormalities without producing clearer clinical decisions.
A reference interval is not automatically a treatment target or a universal “optimal” range. Laboratories may use different methods, units, specimen types, and comparison populations. An out-of-range result may occur in a healthy person, and an in-range result does not guarantee the absence of disease.[8]
Interpretation may be affected by acute illness, inflammation, smoking, alcohol, recent exercise, fasting status, hydration, medications, supplements, kidney or liver function, and collection or processing conditions. Glutathione is especially sensitive to specimen handling and oxidation after collection. An unexpected hs-CRP result obtained during an infection or injury may need to be repeated after recovery.
A higher F2-isoprostane result may be consistent with increased lipid peroxidation, but it does not identify the source. A low total-glutathione result does not establish why it is low or prove that supplementation is appropriate. A normal oxidized LDL, F2-isoprostane, MPO, or glutathione result does not rule out atherosclerosis, hypertension, diabetes, inherited lipid risk, structural heart disease, or impaired blood flow.
There is no universal retesting interval for total glutathione, F2-isoprostanes, oxidized LDL, or cardiovascular MPO. Repeat testing may be reasonable to confirm an unexpected result or evaluate a clinician-guided intervention. When tracking a specialty marker, use comparable preparation conditions and preferably the same laboratory method.
Glutathione biology does not mean that more antioxidants are always better. ROS also have necessary signaling and immune functions. A glutathione or oxidative-stress result does not by itself establish a deficiency, identify a safe dose, or show that a supplement will prevent cardiovascular disease.
The American Heart Association advises against relying on antioxidant vitamin supplements such as vitamins A, C, and E for cardiovascular benefit and recommends meeting nutritional needs primarily through a heart-healthy food pattern.[7] A practical foundation includes avoiding tobacco, following an eating pattern rich in vegetables, fruits, legumes, nuts, seeds, and whole grains, obtaining regular activity appropriate to your health, sleeping adequately, and managing blood pressure, cholesterol, blood sugar, and diagnosed conditions with professional guidance.
Review any proposed antioxidant or glutathione supplement with a qualified healthcare professional, especially if you use prescription medicines, receive cancer treatment, are pregnant, or have kidney or liver disease.
Call 911 or seek emergency medical care for chest pressure or pain, sudden shortness of breath, fainting, cold sweats, unexplained severe nausea, sudden weakness or numbness on one side, facial drooping, sudden difficulty speaking, or another possible heart-attack or stroke symptom. An outpatient oxidative-stress test, lipid result, or normal biomarker cannot determine that acute symptoms are safe.
Eligible adults may be able to order selected cardiovascular and oxidative-stress tests online where available, complete the required blood or urine collection, receive results through a secure account, and use those results for a more informed healthcare discussion. Direct access improves convenience; it does not make every test appropriate, diagnose a condition, or replace a clinician, emergency evaluation, cardiovascular imaging, or treatment plan.
Start with a defined question and the smallest set of tests likely to answer it. Browse Heart & Cardiovascular Tests for the broader cardiovascular pathway, Heart Health Tests for heart-focused options, Cholesterol Tests for lipid-related questions, and Inflammation Tests when a defined inflammation question is present.
No. Oxidative stress is a distributed biological process, not one analyte. Total glutathione, oxidized LDL, and cardiovascular MPO measure different selected markers in blood, while the F2-isoprostane/creatinine ratio measures a lipid-peroxidation marker in urine. None provides a complete body-wide measure.
A Total Glutathione Test may provide information about one component of antioxidant defense. It is not a standard heart-disease screening or diagnostic test and is generally less actionable than established cardiovascular measures. Its use should begin with a specific question and a plan for interpretation.
A higher result may be consistent with increased lipid peroxidation. It does not show where oxidation occurred, identify the cause, or diagnose heart disease. Smoking, metabolic dysfunction, inflammation, illness, and other factors may influence the result.
LDL-C estimates the cholesterol carried within LDL particles. Oxidized LDL measures selected oxidative modification of LDL according to the assay. LDL-C, non-HDL-C, and ApoB have established roles in cardiovascular-risk assessment; oxidized LDL is a specialty adjunct.
No. hs-CRP measures systemic inflammation at low concentrations. Inflammation and oxidative activity interact, but hs-CRP does not measure ROS, lipid peroxidation, glutathione, or artery-specific inflammation.
No. These tests are not recommended as universal cardiovascular screens. Most people should first address blood pressure, conventional lipids, glucose status, smoking, family history, kidney health when appropriate, and overall cardiovascular risk.
Not necessarily. A result does not identify its cause, represent every tissue, or establish a safe or effective supplement plan. Review the result with your medical history, diet, medicines, supplements, organ function, and other findings before making a change.
There is no universal schedule. Repeat only when the result will answer a defined follow-up question, such as confirming an unexpected value or evaluating a clinician-guided intervention. Use comparable conditions and the same method when possible.
No. Normal specialty biomarkers do not rule out coronary plaque, impaired blood flow, structural heart disease, arrhythmia, hypertension, or inherited risk. Symptoms, examination, validated risk assessment, ECG testing, imaging, and other evaluation may still be needed.
Oxidative stress and glutathione are relevant to cardiovascular biology, particularly endothelial function, inflammation, lipid peroxidation, LDL modification, and cellular redox balance. Their biological importance does not make specialty oxidative-stress tests routine heart-disease screens.
Begin with established cardiovascular-risk assessment. Add ApoB, Lp(a), or hs-CRP when each test answers a defined risk question. Consider total glutathione, F2-isoprostanes, oxidized LDL, or cardiovascular MPO only as selective adjuncts, with clear expectations about what the result can and cannot change. Review abnormal, unexpected, or conflicting findings with a qualified healthcare professional before changing medicines, supplements, or health-management decisions.
Originally published: July 10, 2026 | Updated: August 28 2026
These are established contextual tests and should appear before specialty oxidative-stress biomarkers.
These tests refine defined risk questions; they are not oxidative-stress tests.

Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)